1062125

Chiesi USA, Inc. — FEI 3006389494

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 15, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cary, NC (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)